Older adults who use certain heartburn medications for years may have a heightened risk of developing dementia, a new study suggests. The study, published Aug. 9 in the journal Neurology, is the latest to point to potential hazards from prolonged use of medications called proton pump inhibitors, or PPIs. They include such well-known brands as…  read on >  read on >

It may not get the publicity of some better-known vitamins like D, but vitamin K — found in leafy green vegetables — may boost lung health. A new, large study — published Aug. 10 in ERJ Open Research — suggests that people who have low levels of this vitamin also have less healthy lungs. They…  read on >  read on >

Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen and Tulum for irregular pill sales. Last spring, the United States warned of dangerous pill sales to foreigners and tourists where counterfeit drugs contained fentanyl, heroin and methamphetamine. Mexican investigators went to 55 drug stores, finding irregular sales…  read on >  read on >

A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect. Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday. “People living with obesity have an increased risk of cardiovascular disease but, to date, there are no…  read on >  read on >

In the midst of a childhood obesity epidemic, a new study is pointing to a way to help school kids maintain a healthier weight: clean, accessible drinking water. The decidedly low-tech solution emerged in a study of 18 California elementary schools that serve largely low-income minority families. Researchers found that when they kicked off a…  read on >  read on >

Early and gradual exposure to peanuts under medical supervision curbed infants’ allergies, according to a new study. While researchers had seen that peanut oral immunotherapy was well tolerated by toddlers, this research focused on an even younger age group. “We’ve seen how peanut oral immunotherapy is well-tolerated in toddlers, but there is limited real-world evidence…  read on >  read on >

The U.S. Food and Drug Administration on Friday approved a new pill, called zuranolone, that may quickly ease severe postpartum depression and help millions of women regain their emotional equilibrium following childbirth. Taken as a pill once a day for two weeks, zuranolone (Zurzuvae) showed “rapid, significant and sustained” reductions in depressive symptoms when compared…  read on >  read on >